Afegostat
Afegostat (INN; also known as isofagomine; planned trade name Plicera) was an experimental drug for the treatment of certain forms of Gaucher's disease that was being developed by Amicus Therapeutics and Shire plc until a failed clinical trial in 2009 led to termination of its development. The substance was used in form of the tartrate.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Afegostat
Afegostat (INN; also known as isofagomine; planned trade name Plicera) was an experimental drug for the treatment of certain forms of Gaucher's disease that was being developed by Amicus Therapeutics and Shire plc until a failed clinical trial in 2009 led to termination of its development. The substance was used in form of the tartrate.
has abstract
Afegostat (INN; also known as ...... used in form of the tartrate.
@en
alternative name
Plicera
@en
CAS number
169105-89-9
ChEMBL
FDA UNII code
G23AP190YS
KEGG
PubChem
Wikipage page ID
23,365,014
page length (characters) of wiki page
Wikipage revision ID
1,002,678,716
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChEMBL
ChemSpiderID
IUPAC name
IUPHAR ligand
KEGG
D09576
@en
legal status
Development terminated
@en
PubChem
routes of administration
Oral
@en
SMILES
C1[C@@H]CO
@en
StdInChIKey
QPYJXFZUIJOGNX-HSUXUTPPSA-N
@en
synonyms
Isofagomine; AT-2101, HGT-3410
@en
tradename
Plicera
@en
UNII
G23AP190YS
@en
verifiedrevid
443,493,670
wikiPageUsesTemplate
subject
hypernym
comment
Afegostat (INN; also known as ...... used in form of the tartrate.
@en
label
Afegostat
@en